Inorganic phosphate induces cancer cell mediated angiogenesis dependent on forkhead box protein C2 (FOXC2) regulated osteopontin expression.
Recent studies in both rodents and humans suggest that elevated serum phosphorus, in the context of normal renal function, potentiates, or exacerbates pathologies associates with cardiovascular disease, bone metabolism, and cancer. Our recent microarray studies identified the potent stimulation of pro-angiogenic genes such as forkhead box protein C2 (FOXC2), osteopontin, and Vegfα, among others in response to elevated inorganic phosphate (Pi). Increased angiogenesis and neovascularization are important events in tumor growth and the progression to malignancy and FOXC2 has recently been identified as a potential transcriptional regulator of these processes. In this study we addressed the possibility that a high Pi environment would increase the angiogenic potential of cancer cells through a mechanism requiring FOXC2. Our studies utilized lung and breast cancer cell lines in combination with the human umbilical vascular endothelial cell (HUVEC) vessel formation model to better understand the mechanism(s) by which a high Pi environment might alter cancer progression. Exposure of cancer cells to elevated Pi stimulated expression of FOXC2 and conditioned medium from the Pi-stimulated cancer cells stimulated migration and tube formation in the HUVEC model. Mechanistically, we define the requirement of FOXC2 for Pi-induced osteopontin (OPN) expression and secretion from cancer cells as necessary for the angiogenic response. These studies reveal for the first time that cancer cells grown in a high Pi environment promote migration of endothelial cells and tube formation and in so doing identify a novel potential therapeutic target to reduce tumor progression.
Division of Endocrinology, Department of Medicine, Emory University, Atlanta, Georgia.
Yiming
Y
Lin
Division of Endocrinology, Department of Medicine, Emory University, Atlanta, Georgia.|Georgia Gwinnett College, Lawrenceville, Georgia.
Kelly E
KE
McKinnon
Division of Endocrinology, Department of Medicine, Emory University, Atlanta, Georgia.
Shin Woo
SW
Ha
Division of Endocrinology, Department of Medicine, Emory University, Atlanta, Georgia.|The Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.|The Atlanta Department of Veterans Affairs Medical Center, Decatur, Georgia.
George R
GR
Beck
D001940:Breast / Q000098:blood supply / Q000378:metabolism; D001943:Breast Neoplasms / Q000098:blood supply / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D002465:Cell Movement; D005260:Female; D051858:Forkhead Transcription Factors / Q000235:genetics / Q000378:metabolism*; D015972:Gene Expression Regulation, Neoplastic; D061307:Human Umbilical Vein Endothelial Cells; D006801:Humans; D008168:Lung / Q000098:blood supply / Q000378:metabolism; D008175:Lung Neoplasms / Q000098:blood supply / Q000235:genetics / Q000378:metabolism*; D009389:Neovascularization, Pathologic / Q000235:genetics / Q000378:metabolism*; D053495:Osteopontin / Q000235:genetics* / Q000378:metabolism; D010710:Phosphates / Q000378:metabolism*; D059016:Tumor Microenvironment
D051858:Forkhead Transcription Factors; D010710:Phosphates; C082078:mesenchyme fork head 1 protein; D053495:Osteopontin
FOXC2; angiogenesis; inorganic phosphate; migration; osteopontin